Abstract
This article critiques the Drug Price Competition and Patent Term Restoration Act of 1984. Part I traces the background of the two major sections of the Act by examining the recent trend toward generic competition in the pharmaceutical industry and the need perceived by some industry observers for additional incentives to pharmaceutical research. Part II of the article describes and discusses the sections of the Act designed to benefit the two segments of the pharmaceutical industry. Part III addresses the likely effect of the Act on generic competition, and Part IV provides a parallel analysis for the research-intensive pharmaceutical firms. The article offers several suggestions for legislative and administrative initiatives that would strengthen the Act and further its twin goals of generic price competition and adequate incentives for pharmaceutical innovation.
This abstract has been taken from the author's introductory paragraphs.
Document Type
Article
Publication Date
1986
Publication Information
35 Catholic University Law Review 433-487 (1986)
Repository Citation
Wheaton, James J., "Generic Competition and Pharmaceutical Innovation: The Drug Price Competition and Patent Term Restoration Act of 1984" (1986). Faculty Publications. 2138.
https://scholarship.law.wm.edu/facpubs/2138